Bj. Czerniecki et al., Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma, CANCER, 85(5), 1999, pp. 1098-1103
BACKGROUND. Sentinel lymph node (SLN) biopsy is being investigated as a sta
ging procedure for breast carcinoma. The authors evaluated whether immunohi
stochemical (IHC) analysis improves the sensitivity of this procedure.
METHODS. Forty-four women dth breast carcinoma were recruited for SLN biops
y. Preoperative lymphoscintigraphy tvas followed by intraoperative localiza
tion using a handheld gamma probe and blue dye. After SLN identification, a
n immediate complete axillary lymph node dissection was performed in all pa
tients. All lymph nodes were subjected to routine histology (hematoxylin an
d eosin [H&E]) and IHC using antibody to cytokeratins.
RESULTS. The SLN was identified in 41 of 43 patients (95%), Successful SLN
identification was independent of biopsy technique (open surgical [95%] vs.
fine-needle aspiration/core needle biopsy [96%]). Twelve of 41 patients (2
9%) had evidence of lymph node metastasis in the SLN by routine histology.
Of the twenty-nine patients with H&E negative SLN, 3 were found to have met
astasis by MC for a conversion rate of 10%. Fifteen of 41 patients (37%) ha
d evidence of metastasis in SW. All 26 patients with H&E and IHC negative S
LN had negative nonsentinel lymph nodes by routine histology and MC (100% n
egative predictive value). All patients with tumors < 2 cm and micrometasta
sis to the SLN had no additional lymph node disease, in contrast to patient
s with lesions > 2 cm or patients with macrometastasis to the SLN (P = 0.00
7).
CONCLUSIONS. These results confirm that SLN biopsy is extremely accurate fo
r patients with breast carcinoma, even after open surgical biopsy. IHC anal
ysis or serial sectioning of SLN improves the sensitivity of this staging t
echnique. Cancer 1999;85:1098-103, (C) 1999 American Cancer Society.